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FCS, 1% P/S and 1% L-glutamine. The synoviocytes (100,000
cells per well on a plate with 24 wells with 250 μl of culture
medium) were incubated with IB0004 and ID386 for 12 and 24
hours at concentrations of 1 μg/mL, 10 μg/mL, 100 μg/mL, 200
μg/mL. ID386 was also tested at a concentration of 1000 μg/mL.
Prescription, pure HA extract was used as a positive control at a
concentration of 200 μg/mL. Negative control was the synoviocyte
culture alone. After incubation, the supernatant was then collected
from the different wells. The endogenous HA (eHA) content was
measured by ELISA (Corgenix Inc., USA). The results are pre-
sented as the mean ± SD of the 9 individual experiments carried
out in the cultures. Statistical analysis was performed using Stu-
dent’s two-tailed t-test for unpaired data, p values were calculated
versus baseline eHA levels.
Results: Baseline levels of endogenous HA in the cell cultures
with no interventions were 710 (±107) and 1867 (±335) ng/ml
after 12 and 24 hours treatment, respectively. As expected, the
positive control group resulted in a signiﬁcant production of eHA
(p<0.05). IB0004 dose dependently induced the expression of
endogenous HA in human OA synoviocytes after 12 h and 24
h treatment. Human OA synoviocytes treated with 100 μg/ml of
IB0004 for 12 h and 24 h produced 49,166 (±2,888, p<0.05)
and 50,300 (±2,648, p<0.05) ng/ml endogenous HA, respectively.
OA synoviocytes stimulated with 200 μg/ml of IB0004 for 12 and
24 h produced 104,625 (±3,159, p<0.05) and 110,454 (±15,666,
p<0.05) ng/ml endogenous HA, respectively. ID386 stimulated
OA synoviocytes at 1000 μg/ml produced only 1,702 (±139) and
2,489 (±176) ng/ml for 12 h and 24 h treatment, respectively, with
even lower amounts of eHA produced at the lower concentrations
(p= n.s. for all ID386 groups). See Figure 1.
Conclusions: IB0004 treatment of OA synoviocytes signiﬁcantly
increased endogenous HA production in a dose dependent man-
ner, and the most effective dose was 200 μg/ml, whereas, ID386
had a negligible effect on the production of endogenous HA, even
at the dose of 1000 μg/ml.
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Purpose: The purpose of this study was to determine the in vivo
loads across the knee joint during activities of daily living and in
golf.
Methods: Three patients with electronic sensors in their knee
replacement implants were tested during activities of daily living
and during the golf swing.
Results: The results showed the axial loads for normal walking are
2.5 times body weight with each step. Axial unloading was possible
with a novel proprietary insole. A cane in the opposite hand
reduced the load up to 66% on affected knee. Medial and lateral
compartment loads were dependent on the axial alignment of
the knee. Compartment unloading was possible with a cushioned
wedged insole up to 50% in one subject. An unloader brace
had no effect on lateral compartment unloading during gait or
the golf swing. The loads during the golf swing are much higher
than anticipated, being simultaneously at ball impact 3.25 × body
weight on the back knee while 4.5 × body weight on the front knee.
Unloading during the golf swing is possible with use of cushioned
wedged insoles, shoes with soft spikes and use of shorter golf
club during extended practice.
Conclusions: Abnormal loading of the knee joint may result
in osteoarthritis. The medical literature supports the notion that
unloading the knee may have a therapeutic effect on the os-
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teoarthritic knee. This information should be a helpful adjunct for
non-operative management of the patient with osteoarthritis of the
knee.
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Purpose: Hyaluronic acid (HA) is a main glycosaminoglycan
present in synovial ﬂuid, synthesized by synovial ﬁbroblasts and
chondrocytes. HA provides a variety of mechanical and biochem-
ical properties. Osteoarthritis (OA) patients exhibit a low endoge-
nous HA and intra-articular administration of HA (either from
extraction or fermentation) is currently an accepted therapy for
OA. One of the proposed mechanisms of action for exogenous HA
is the production of endogenous HA. This study was performed
to determine the in-vitro effects of three compounds: IB0004 (a
natural rooster comb extract rich in HA designed for oral ad-
ministration), extracted HA (HA-E) and fermented (HA-F), both
injectable products, on the synthesis of endogenous HA (eHA) in
human synoviocytes.
Methods: Cultured human synoviocytes obtained from patients
undergoing joint replacement. The synovial tissue was cut into 2
mm3 fragments and washed three times with culture medium (2%
RPMI P/S/A). The synovium was digested by adding 25 mL of
